Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 4 | +40.8K | 100% | $1.21 | +$49.5K |
Sells | 0 | ||||
Net | +4 | +40.8K | 100% | +$49.5K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
David A. Dodd | President, CEO, Director | $39.6K | +$26.4K | +200% | Apr 1, 2025 |
Mark Reynolds | Cfo | $15.1K | +$7.34K | +94.3% | Mar 31, 2025 |
Kelly T. McKee | Chief Medical Officer | $12.9K | Aug 12, 2024 | ||
John N. Spencer Jr | Director | $11.2K | +$9.8K | +713% | Apr 10, 2025 |
John Sharkey | VP, Business Development | $6.13K | +$5.94K | +3143% | Apr 10, 2025 |
Jayne Morgan | Director | Aug 12, 2024 | |||
Dean Kollintzas | Director | Aug 12, 2024 | |||
Nicole Lemerond | Director | Aug 12, 2024 | |||
Mark Newman | Chief Scientific Officer | Aug 12, 2024 | |||
T. Mcnally | Director | Aug 12, 2024 | |||
Randal Chase | Director | Aug 12, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|